8.2.3 Anti-lymphocyte monoclonal antibodies
Alemtuzumab
Lemtrada 12mg/1.2ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Multiple sclerosis |
Rituximab
Rituximab 100mg/10ml solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Nutrition and blood | Acquired haemophilia |
Rituximab 500mg/50ml solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Nutrition and blood | Acquired haemophilia |
| Skin | Autoimmune bullous dermatoses |